Cargando…

Value of Dedicated Head and Neck (18)F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative (131)I Whole-body Scan

OBJECTIVE(S): In clinical practice, approximately 10-25% of post-surgical differentiated thyroid carcinoma (DTC) patients with high serum thyroglobulin (Tg) and negative (131)I whole-body scan (WBS) have poor prognosis due to recurrent or metastatic lesions after radioactive iodine treatment. The pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Mai Hong, Bieu, Bui Quang, Ha, Le Ngoc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia Oceania Journal of Nuclear Medicine & Biology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937675/ https://www.ncbi.nlm.nih.gov/pubmed/27904869 http://dx.doi.org/10.7508/aojnmb.2016.04.003

Ejemplares similares

The Prognostic Value of Sequential (18) F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy
por: Ha, Le Ngoc, et al.
Publicado: (2023)

Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin
por: Boktor, Raef R., et al.
Publicado: (2022)

Value of (18)F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative (131)I Whole-Body Scan and Elevated Thyroglobulin Levels
por: Li, Hongyan, et al.
Publicado: (2021)

Predicting (131)I-avidity of metastases from differentiated thyroid cancer using (18)F-FDG PET/CT in postoperative patients with elevated thyroglobulin
por: Liu, Min, et al.
Publicado: (2018)

Prognostic Role of 2-[(18)F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative (131)I WBS and Positive 2-[(18)F]-FDG PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

A dedicated paediatric [(18)F]FDG PET/CT dosage regimen
por: Cox, Christina P. W., et al.
Publicado: (2021)

Fasting Hypoglycemia on (18)F-FDG PET/CT Scan
por: Nakayama, Michihiro, et al.
Publicado: (2017)

Incidental “Urinoma” in (18)F-FDG PET/CT Scan
por: Gültekin, Aziz, et al.
Publicado: (2019)

(18)F-FDG PET/CT and Whole-Body Bone Scan Findings in Gorlin–Goltz Syndrome
por: Cheon, Miju, et al.
Publicado: (2023)

Incremental Value of a Dedicated Head and Neck Acquisition during (18)F-FDG PET/CT in Patients with Differentiated Thyroid Cancer
por: Ciappuccini, Renaud, et al.
Publicado: (2016)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

Impact of Renal Failure on F18-FDG PET/CT Scans
por: Kode, Vishwajit, et al.
Publicado: (2017)

The validation of low-dose CT scans from the [(18)F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans
por: Zwart, Aniek T., et al.
Publicado: (2023)

Quantitative techniques in (18)FDG PET scanning in oncology
por: Castell, F, et al.
Publicado: (2008)

Estimation of radiation dose to patients from (18)FDG whole body PET/CT investigations using dynamic PET scan protocol
por: Kaushik, Aruna, et al.
Publicado: (2015)

Hypoxia is important in F-18 FDG accumulation in thecoma-fibroma tumors on F-18 FDG PET/CT scans
por: SEINO, HIROKO, et al.
Publicado: (2016)

F18-FDG PET/CT Scanning in Angiosarcoma: Report of Two Cases
por: Tokmak, Emel, et al.
Publicado: (2011)

A quantitative comparison of gross tumour volumes delineated on [18F]-FDG PET-CT scan and CECT scan in head and neck cancers
por: Venkada, Manickam G, et al.
Publicado: (2012)

Inclusion of brain in FDG PET/CT scanning techniques in cancer patients: Does it obviate the need for dedicated brain imaging?
por: Purandare, Nilendu C
Publicado: (2011)

Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005)

Contribution of (18)F-FDG PET/CT to Staging of Head and Neck Malignancies
por: Ceylan, Yeşim, et al.
Publicado: (2018)

Utility of (99m)Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer Patients with Elevated Serum Thyroglobulin Levels
por: Shinto, Ajit S., et al.
Publicado: (2015)

Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck (18)FDG PET/CT imaging in differentiated thyroid cancer
por: Ciappuccini, Renaud, et al.
Publicado: (2018)

Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [(18)F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
por: Albano, Domenico, et al.
Publicado: (2020)

Superscan caused by renal osteodystrophy: Observed on 18F FDG PET/CT scan
por: Ghesani, Nasrin, et al.
Publicado: (2013)

Evaluation of pituitary uptake incidentally identified on (18)F-FDG PET/CT scan
por: Ju, Huijun, et al.
Publicado: (2017)

Isolated Extranodal Rosai-Dorfman Disease on 18F-FDG PET-CT Scan
por: Gupta, Nitin, et al.
Publicado: (2019)

Visualization of Dialysis-Related Amyloid Arthropathy on (18)F-FDG PET-CT Scan
por: Cheon, Miju, et al.
Publicado: (2022)

Computational approaches to detect small lesions in (18)F‐FDG PET/CT scans
por: Nichols, Kenneth J., et al.
Publicado: (2021)

Mesenteric Panniculitis Appears as Metastatic Disease on (18)F-FDG-PET/CT Scan
por: Ekmekçioğlu, Özgül, et al.
Publicado: (2022)

Incidental findings on 18-FDG PET–CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET–CT in patients with head and neck cancer
por: Casselden, Elizabeth, et al.
Publicado: (2018)

Clinical Value of (99m)Tc-3PRGD2 SPECT/CT in Differentiated Thyroid Carcinoma with Negative (131)I Whole-Body Scan and Elevated Thyroglobulin Level
por: Gao, Rui, et al.
Publicado: (2018)

Whole-Body Parametric Imaging of (18)F-FDG PET Using uEXPLORER with Reduced Scanning Time
por: Wu, Yaping, et al.
Publicado: (2022)

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma
por: CASTALDI, P., et al.
Publicado: (2013)

Clinical utility of 18 Fluorodeoxyglucose (FDG)-PET/CT scans in patients with suspect ocular tuberculosis
por: Mehta, Salil
Publicado: (2013)

A potential diagnostic role of dual-phase 18F-FDG PET/CT scanning
por: Jones, Clare, et al.
Publicado: (2014)

Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
por: Huang, Bingsheng, et al.
Publicado: (2015)

Peritoneal Super Scan on (18)F - FDG PET-CT in a Patient of Burkitt's Lymphoma
por: Roy, Shambo Guha, et al.
Publicado: (2017)

(18)FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19
por: Karimi-Galougahi, Mahboobeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rfat9ch59bbkh4rh4kdsm77nl